Canlyniadau Chwilio - Kirk E. Evoy

Editorial: Reviews in opioid use disorders gan Wendy Walwyn, Kirk E. Evoy, Kirk E. Evoy

Connect to this object online.

Kratom as a potential substance use disorder harm reduction agent gan MeShell Green, Nina Vadiei, Nina Vadiei, Charles A. Veltri, Oliver Grundmann, Oliver Grundmann, Kirk E. Evoy, Kirk E. Evoy

Connect to this object online.

Gabapentin for Off-Label Use: Evidence-Based or Cause for Concern? gan Alyssa M Peckham, Kirk E Evoy, Leslie Ochs, Jordan R Covvey

Connect to this object online.

Comparison of Quetiapine Abuse and Misuse Reports to the FDA Adverse Event Reporting System With Other Second-Generation Antipsychotics gan Kirk E Evoy, Chengwen Teng, Victor G Encarnacion, Brian Frescas, John Hakim, Stephen Saklad, Christopher R Frei

Connect to this object online.

Receipt of Substance Use Counseling Among Ambulatory Patients Prescribed Opioids in the United States gan Kirk E Evoy, Charles E Leonard, Jordan R Covvey, Leslie Ochs, Alyssa M Peckham, Samantha Soprano, Kelly R Reveles

Connect to this object online.

Quetiapine and olanzapine misuse prevalence in a US general population sample gan Kirk E Evoy, PharmD, BCACP, BC-ADM, CTTS, Shelby Humpert, PharmD, Sorina Torrez, PharmD, Haneen Hussein, PharmD, Jordan R Covvey, PharmD, PhD, BCPS

Connect to this object online.

Characterization of hospitalized patients who received naloxone while receiving opioids with or without gabapentinoids gan Payal H. Desai, PharmD, BCCCP, Olesya Taylor, PharmD, BCPS, Kunal J. Shah, PharmD, Kirk E. Evoy, PharmD, BCACP, BC-ADM, CTTS, Alyssa M. Peckham, PharmD, BCPP

Connect to this object online.